DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,015 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $24,034,071 | -0.9% | 96,194 | -0.9% | 0.25% | -3.1% |
Q1 2024 | $24,240,320 | +11.4% | 97,070 | +3.2% | 0.25% | -2.7% |
Q4 2023 | $21,769,325 | +2.2% | 94,101 | +9.6% | 0.26% | -10.0% |
Q3 2023 | $21,299,137 | +4.8% | 85,849 | +1.4% | 0.29% | +7.0% |
Q2 2023 | $20,321,280 | -8.6% | 84,672 | -4.0% | 0.27% | -16.6% |
Q1 2023 | $22,227,912 | -2.3% | 88,192 | +2.9% | 0.32% | -11.9% |
Q4 2022 | $22,750,210 | +19.7% | 85,714 | +16.5% | 0.37% | +1.1% |
Q3 2022 | $19,001,000 | +17.6% | 73,566 | +15.5% | 0.36% | +12.7% |
Q2 2022 | $16,152,000 | -22.1% | 63,712 | -9.9% | 0.32% | -6.1% |
Q1 2022 | $20,731,000 | -9.9% | 70,674 | +1.0% | 0.34% | -4.4% |
Q4 2021 | $23,021,000 | +24.5% | 69,970 | +15.2% | 0.36% | +2.8% |
Q3 2021 | $18,493,000 | +7.7% | 60,744 | -5.0% | 0.35% | +11.4% |
Q2 2021 | $17,164,000 | +94.7% | 63,958 | +63.3% | 0.32% | +68.4% |
Q1 2021 | $8,816,000 | +1.0% | 39,169 | -0.4% | 0.19% | -1.6% |
Q4 2020 | $8,732,000 | +6.5% | 39,310 | +3.3% | 0.19% | -5.5% |
Q3 2020 | $8,197,000 | +80.6% | 38,069 | +48.3% | 0.20% | +71.8% |
Q2 2020 | $4,539,000 | – | 25,669 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |